Everything about Healthcare News
Novo CEO pressed by Senate to cut prices of obesity, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the company would contemplate new talks with insurers with regard to the record costs of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies.Sanders quickly condemned the go in a s